Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMO-01 in Phelan-McDermid Syndrome
NCT03493607Phase 2Completed
- Start
- May 2018
- Primary completion
- Mar 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of diazepinomicin in Phelan-McDermid syndrome (PMS). Started May 2018; status: completed.
02
Drugs
diazepinomicin
03
Conditions
Phelan-McDermid syndrome (PMS)
Beyond the preview
Go deeper on NCT03493607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03493607.